Robert E. W. Hancock
TitleCited byYear
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
CK Stover, XQ Pham, AL Erwin, SD Mizoguchi, P Warrener, MJ Hickey, ...
Nature 406 (6799), 959, 2000
39672000
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
REW Hancock, HG Sahl
Nature biotechnology 24 (12), 1551, 2006
28202006
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
I Wiegand, K Hilpert, REW Hancock
Nature protocols 3 (2), 163, 2008
22112008
Peptide antimicrobial agents
H Jenssen, P Hamill, REW Hancock
Clinical microbiology reviews 19 (3), 491-511, 2006
20092006
Cationic peptides: a new source of antibiotics
REW Hancock, R Lehrer
Trends in biotechnology 16 (2), 82-88, 1998
15441998
Peptide antibiotics
REW Hancock, DS Chapple
Antimicrobial agents and chemotherapy 43 (6), 1317-1323, 1999
15031999
Peptide antibiotics
REW Hancock
The Lancet 349 (9049), 418-422, 1997
13791997
The role of cationic antimicrobial peptides in innate host defences
REW Hancock, G Diamond
Trends in microbiology 8 (9), 402-410, 2000
12142000
Cationic peptides: effectors in innate immunity and novel antimicrobials
REW Hancock
The Lancet infectious diseases 1 (3), 156-164, 2001
10412001
The role of antimicrobial peptides in animal defenses
REW Hancock, MG Scott
Proceedings of the national Academy of Sciences 97 (16), 8856-8861, 2000
10122000
Designing antimicrobial peptides: form follows function
CD Fjell, JA Hiss, REW Hancock, G Schneider
Nature reviews Drug discovery 11 (1), 37, 2012
9812012
The relationship between peptide structure and antibacterial activity
JPS Powers, REW Hancock
Peptides 24 (11), 1681-1691, 2003
8522003
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
AK Marr, WJ Gooderham, REW Hancock
Current opinion in pharmacology 6 (5), 468-472, 2006
8042006
Cationic host defense (antimicrobial) peptides
KL Brown, REW Hancock
Current opinion in immunology 18 (1), 24-30, 2006
7432006
Resistance Mechanisms in Pseudomonas aeruginosa and Other Nonfermentative Gram-Negative Bacteria
REW Hancock
Clinical Infectious Diseases 27 (Supplement_1), S93-S99, 1998
7141998
Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli
M Wu, E Maier, R Benz, REW Hancock
Biochemistry 38 (22), 7235-7242, 1999
7051999
The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses
MG Scott, DJ Davidson, MR Gold, D Bowdish, REW Hancock
The journal of immunology 169 (7), 3883-3891, 2002
6612002
Biochemical model for enhanced biological phosphorus removal
Y Comeau, KJ Hall, REW Hancock, WK Oldham
Water Research 20 (12), 1511-1521, 1986
6421986
Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains.
RP Darveau, RE Hancock
Journal of bacteriology 155 (2), 831-838, 1983
6211983
Pseudomonas aeruginosa: all roads lead to resistance
EBM Breidenstein, C de la Fuente-Nez, REW Hancock
Trends in microbiology 19 (8), 419-426, 2011
5952011
The system can't perform the operation now. Try again later.
Articles 1–20